|
시장보고서
상품코드
2077993
유전체학용 인공지능(AI) 시장 : 제공 방식별, 기능별, 용도별, 최종사용자별, 지역별Artificial Intelligence (AI) in Genomics Market, By Delivery Mode, By Functionality, By Application, By End User, By Region (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific) |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
유전체학용 인공지능(AI) 시장 규모는 2026년에 39억 1,000만 달러, 2033년까지 677억 1,000만 달러에 이를 전망입니다. 또한, 2026-2033년 CAGR 50.3%를 기록할 것으로 예측됩니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준연도 | 2025년 | 시장 규모(2026년) | 39억 1,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR | 50.30% | 예측 금액(2033년) | 677억 1,000만 달러 |
인공지능(AI) 기술은 유전체 의학의 발전에 큰 가능성을 지니고 있습니다. AI 기술인 머신러닝과 그 일종인 딥러닝은 유전체 의학 분야의 주요 분석 과제를 효율적으로 해결하기 위한 새로운 계산 기법을 제공합니다.
시장 역학:
신약 개발 및 진단 분야의 처리 시간 단축에 대한 관심이 높아지고 있는 점, AI 기반 솔루션의 도입 확대, 그리고 생의학 및 유전체 데이터 세트 증가가 예측 기간 동안 전 세계 유전체학용 인공지능(AI) 시장의 성장을 견인할 것으로 예상되는 주요 요인입니다.
예를 들어, 2020년 11월, BioMarin Pharmaceutical Inc.와 Deep Genomics는 Deep Genomics의 인공지능 신약 개발 플랫폼('The AI Workbench')을 활용하여, 미충족 의료 수요가 높은 4가지 희귀질환 적응증에 대한 올리고뉴클레오티드 계열 신약 후보 물질을 선별하기 위한 전임상 공동 연구를 시작했다고 발표했습니다.
본 보고서의 주요 특징
- 본 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 시장 성장 촉진요인 및 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
- 전 세계 유전체학 분야 인공지능(AI) 시장의 주요 기업 프로파일을 각종 지표(기업 개요, 제품 포트폴리오, 주요 동향, 재무 실적, 전략 등)를 바탕으로 소개했습니다.
- 본 보고서의 인사이트를 바탕으로, 마케팅 담당자와 기업 경영진은 향후 제품 출시, 기술 업데이트, 시장 확대 및 마케팅 전략에 관해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- '세계 유전체학용 인공지능(AI) 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자들을 대상으로 합니다.
- 이해관계자들은 전 세계 유전체학용 인공지능(AI) 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 유전체학용 인공지능(AI) 시장
제5장 세계의 유전체학용 인공지능(AI) 시장 : 제공 방식별(2021-2033년)
제6장 세계의 유전체학용 인공지능(AI) 시장 : 기능별(2021-2033년)
제7장 세계의 유전체학용 인공지능(AI) 시장 : 용도별(2021-2033년)
제8장 세계의 유전체학용 인공지능(AI) 시장 : 최종사용자별(2021-2033년)
제9장 세계의 유전체학용 인공지능(AI) 시장 : 지역별(2021-2033년)
제10장 경쟁 구도
제11장 섹션
LSH 26.07.13Artificial Intelligence (AI) in Genomics Market is estimated to be valued at USD 3.91 Bn in 2026 and is expected to reach USD 67.71 Bn by 2033, growing at a compound annual growth rate (CAGR) of 50.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3.91 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 50.30% | 2033 Value Projection: | USD 67.71 Bn |
Artificial intelligence (AI) techniques offer great potential for advancing genomic medicine. The AI techniques machine learning and deep learning, a type of machine learning offer new computational approaches to streamlining key analytical problems in genomic medicine
Market Dynamics:
Rising Focus on Reducing Turnaround Time in Drug Discovery & Diagnostics, Growing Adoption of Ai-Based Solutions, and Increased Biomedical and Genomic Datasets are major factors expected to augment growth of the global artificial intelligence (ai) in genomics market over the forecast period.
For instance, in November 2020, BioMarin Pharmaceutical Inc., and Deep Genomics announced that the companies have entered into a preclinical collaboration that will use Deep Genomics artificial intelligence drug discovery platform (The AI Workbench) to identify oligonucleotide drug candidates in four rare disease indications with high unmet need.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global artificial intelligence (ai) in genomics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Fabric Genomics, International Business Machines, Microsoft, NVIDIA, AI Therapeutics, Ares Genetics, Benevolent AI, Deep Genomics, Diploid, and among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global artificial intelligence (AI) in genomics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence (ai) in genomics market.
Detailed Segmentation:
- Global Artificial Intelligence (AI) in Genomics Market, By Delivery Mode (Revenue, USD Bn, 2021 - 2033)
- On-Premises
- Cloud-Based
- Global Artificial Intelligence (AI) in Genomics Market, By Functionality (Revenue, USD Bn, 2021 - 2033)
- Genome Sequencing
- Gene Editing
- Others
- Global Artificial Intelligence (AI) in Genomics Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Translational Precision Medicine
- Clinical & Genomic Diagnostics
- Others Applications
- Global Artificial Intelligence (AI) in Genomics Market, By End User (Revenue, USD Bn, 2021 - 2033)
- Pharma & Biotech Companies
- Public & Consumer Genomic Center
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles:
- Fabric Genomics
- International Business Machines
- MICROSOFT
- NVIDIA
- AI Therapeutics
- Ares Genetics
- Benevolent AI
- Deep Genomics
- Diploid
Table of Contents:
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Delivery Mode
- Market Snapshot, By Functionality
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rising Focus on Reducing Turnaround Time in Drug Discovery & Diagnostics
- Growing Adoption of Ai-Based Solutions
- Increased Biomedical and Genomic Datasets
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER€(TM)s Analysis
- Merger and Acquisition Scenario
4. Global Artificial Intelligence in Genomics Market
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Artificial Intelligence in Genomics Market, By Delivery Mode, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- On-Premises
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Cloud-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
6. Global Artificial Intelligence in Genomics Market, By Functionality, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Genome Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Gene Editing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
7. Global Artificial Intelligence in Genomics Market, By Application, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Translational Precision Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Clinical & Genomic Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
8. Global Artificial Intelligence in Genomics Market, By End User, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharma & Biotech Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Public & Consumer Genomic Center
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
9. Global Artificial Intelligence in Genomics Market, By Geography, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Functionality, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Functionality, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Functionality, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Functionality, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Functionality, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Functionality, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
10. Competitive Landscape
- Fabric Genomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- International Business Machines
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Microsoft
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- NVIDIA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AI Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ares Genetics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BENEVOLENTAI
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Deep Genomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Diploid
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
11. Section
- Research Methodology
- About us
